Company: CERO
Filing Date: 2025-11-20
Form Type: 424B3
Source: 0001213900-25-113118
Chunk: 121

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-20
Form: 424B3
Chunk 121
---
 and regulations of the SEC) applicable to the financial statements that were required
by the applicable accounting requirements and other rules and regulations of the SEC to be included in such filing (including pro forma
financial information); thus, we have not remained timely in our reporting requirements with the SEC since we became an SEC reporting
company on February 14, 2024. Although we regained status as a current filer by filing a Form 8-K/A with current financial statements
on April 1, 2024, we were unable to remain timely in our reporting requirements as a result of our failure to file our Quarterly Report
on Form 10-Q for the period ended June 30, 2025 by August 19, 2025, the extended deadline resulting from our filing of a notice on Form
12b-25 on August 15, 2025, as a result, we will not be eligible to file any new registration statement on Form S-3 and, following any
requirement to amend any existing registration statement on Form S-3, including as a result of the updating of such registration statement
pursuant to Section 10(a)(3) of the Securities Act upon the filing of our Annual Report on Form 10-K for the fiscal year ending December
31, 2025, we will not be eligible to use any existing registration statement on Form S-3, in each case, that would allow us to continuously
incorporate by reference our SEC reports into the registration statement, or to use “shelf” registration statements to conduct
offerings, until approximately one year from the date we regained (and maintain) status as a current and timely filer. Until such time,
if we determine to pursue an offering, we would be required to conduct the offering on an exempt basis, such as in accordance with Rule
144A, or file a registration statement on Form S-1. Using a Form S-1 registration statement for a public offering would likely take significantly
longer than using a registration statement on Form S-3 and increase our transaction costs, and could, to the extent we are not able to
conduct offerings using alternative methods, adversely impact our liquidity, ability to raise capital or complete acquisitions in a timely
manner. The use of Form S-1 would also prevent us from conducting offerings on a “shelf basis,” limiting our flexibility as
to the terms, timing or manner of any such offering.

<div align='center'>50</div>

We cannot guarantee